Author

J. A. Englund

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Assay:proteomics· 3 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. B. Stuart· 2 shared A. L. Greninger· 2 shared E. Seydoux· 2 shared H. Chu· 2 shared H. Y. Chu· 2 shared J. D. Bloom· 2 shared J. Feng· 2 shared L. Stamatatos· 2 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. B. Stuart

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin

F. C. Welsh, R. T. Eguia, J. M. Lee, H. K. Haddox, J. Galloway, N. V. Vinh, A. N. Loes, J. Huddleston, T. C. Yu, M. Q. Le, N. T. Nhat, N. T. L. Thanh, A. L. Greninger, H. Y. Chu, J. A. Englund, , J. D. Bloom

The paper maps how HA mutations affect neutralization by serum from different age groups, showing age-dependent antigenic effects and implications for viral evolution.

bioRxiv · Dec 12, 2023Microbiology

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects

M. Jennewein, A. MacCamey, N. Akins, J. Feng, L. Homad, N. Hurlburt, E. Seydoux, Y.-H. Wang, A. B. Stuart, V. V. Edara, K. Floyd, A. Vanderheiden, J. R. Mascola, N. Doria-Rose, L. Wang, , L. Stamatatos

The paper isolates and characterizes cross-neutralizing antibodies from COVID-19 patients, identifying antibodies that neutralize both SARS-CoV-1 and SARS-CoV-2, including variants.

bioRxiv · Mar 23, 2021 · PreprintImmunology

A human coronavirus evolves antigenically to escape antibody immunity

R. Eguia, K. H. D. Crawford, T. Stevens-Ayers, L. Kelnhofer-Millevolte, A. L. Greninger, J. A. Englund, M. J. Boeckh, J. D. Bloom

This study shows that human coronavirus 229E evolves antigenically to escape antibody immunity, suggesting the need for periodic vaccine updates.

bioRxiv · Dec 17, 2020Microbiology

Evaluating Specimen Quality and Results from a Community-Wide, Home-Based Respiratory Surveillance Study

A. E. Kim, E. Brandstetter, N. Wilcox, J. Heimonen, C. Graham, P. D. Han, L. M. Starita, D. J. McCulloch, A. M. Casto, D. A. Nickerson, M. M. Van de Loo, J. Mooney, M. Ilcisin, K. A. Fay, J. Lee, , H. Chu

The paper evaluates the quality of specimens and results from a home-based respiratory surveillance study to assess its feasibility for community-level monitoring of respiratory pathogens.

bioRxiv · Dec 7, 2020Microbiology

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual

E. Seydoux, L. J. Homad, A. J. MacCamy, K. R. Parks, N. K. Hurlburt, M. F. Jennewein, N. R. Akins, A. B. Stuart, Y.-H. Wan, J. Feng, R. Nelson, S. Singh, K. W. Cohen, J. M. McElrath, J. A. Englund, , L. Stamatatos

This study characterizes neutralizing antibodies from a SARS-CoV-2 infected individual, finding that most antibodies are non-neutralizing and target epitopes outside the RBD, while two potent neutralizers bind the RBD with minimal mutation.

bioRxiv · May 12, 2020 · PreprintImmunology